Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China flag China · Delayed Price · Currency is CNY
25.35
-0.83 (-3.17%)
Sep 24, 2026, 3:00 PM CST

SHA:688321 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
678.16347.75375.55375.9508.98300.55
Short-Term Investments
156.06--257.52181.6100.09
Trading Asset Securities
701.43295.394.13216.72291.0782.08
Cash & Short-Term Investments
1,536643.05469.69850.14981.65482.71
Cash Growth
170.76%36.91%-44.75%-13.40%103.36%-31.19%
Accounts Receivable
323.22299.79162.97196.82154.81111.44
Other Receivables
6.344.971321.7111.629.17
Receivables
329.56304.76175.97218.53166.43120.62
Inventory
66.4857.6840.8447.1328.4715.37
Prepaid Expenses
-----1.69
Other Current Assets
12.26174.9396.9714.297.5818.43
Total Current Assets
1,9441,1801,0831,1301,184638.82
Property, Plant & Equipment
1,4571,2931,1581,0661,100698.99
Long-Term Investments
295.62228.86245.63268.9429.83-
Other Intangible Assets
402.22417.82448.29183.99202.8216.18
Long-Term Deferred Tax Assets
2.632.91.532.0824.6722.03
Long-Term Deferred Charges
308.08255.64168.3403.8270.53145.93
Other Long-Term Assets
190.64271.78146.14148.2783.81172.46
Total Assets
4,6003,6503,2513,2032,8961,894

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
10.293.782.199.030.322.23
Accrued Expenses
185.49177.5142.03120.277.465.82
Short-Term Debt
140.68159.8100.22130.11185.78120.15
Current Portion of Long-Term Debt
268.4342.79133.6636.1919.8817.92
Current Portion of Leases
3.113.333.542.842.894.76
Current Income Taxes Payable
---0.1712.0710.77
Current Unearned Revenue
0.880.150.170.080.230.29
Other Current Liabilities
208.06156.5569.592.18241.9671.89
Total Current Liabilities
816.91843.9451.31390.81540.54293.84
Long-Term Debt
1,0901,0351,088899.17598.024.88
Long-Term Leases
3.74.897.7610.061.291.42
Long-Term Unearned Revenue
98.96101.483.3577.0486.9678.94
Long-Term Deferred Tax Liabilities
39.9238.8838.9623.45--
Other Long-Term Liabilities
0.150.16092.8393.2997.71
Total Liabilities
2,0502,0251,6701,4931,320476.79

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
442.94407.81407.8411.29410.72410.72
Additional Paid-In Capital
1,9221,0231,0131,1381,0751,125
Retained Earnings
124.9579.2228.26142.8353.9936.51
Treasury Stock
-69-15--113.07-154.59-154.59
Comprehensive Income & Other
129.55130.8131.84131.09130.05-0.29
Total Common Equity
2,5501,6261,5811,7101,5151,418
Minority Interest
----60.23-
Shareholders' Equity
2,5501,6261,5811,7101,5761,418
Total Liabilities & Equity
4,6003,6503,2513,2032,8961,894

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,5061,5461,3341,078807.87149.14
Net Cash (Debt)
29.53-903.19-863.9-228.24173.78333.58
Net Cash Growth
-----47.90%-48.17%
Net Cash Per Share
0.07-2.22-2.12-0.560.430.81
Filing Date Shares Outstanding
442.07442.34407.8409.01406.97406.97
Total Common Shares Outstanding
442.07407.27407.8409.01406.97406.97
Working Capital
1,127336.49632.16739.28643.59344.98
Book Value Per Share
5.773.993.884.183.723.48
Tangible Book Value
2,1481,2081,1331,5261,3131,201
Tangible Book Value Per Share
4.862.972.783.733.232.95
Buildings
949.66908.16745.57656.92722.9471.88
Machinery
202.79160.2118.55108.28112.9390.43
Construction In Progress
451.14351.4384.86360.81308.1157.75